67 related articles for article (PubMed ID: 38516189)
1. Radiomic Models Predict Tumor Microenvironment Using Artificial Intelligence-the Novel Biomarkers in Breast Cancer Immune Microenvironment.
Lin G; Wang X; Ye H; Cao W
Technol Cancer Res Treat; 2023; 22():15330338231218227. PubMed ID: 38111330
[TBL] [Abstract][Full Text] [Related]
2. Editorial: New progress in cancer biomarkers and therapy.
Sun G; He C; Wang J
Front Mol Biosci; 2024; 11():1388872. PubMed ID: 38516189
[No Abstract] [Full Text] [Related]
3. Identification of Novel Diagnostic Biomarkers in Prostate Adenocarcinoma Based on the Stromal-Immune Score and Analysis of the WGCNA and ceRNA Network.
Zhang T; Wang Y; Dong Y; Liu L; Han Y; Wang H; Wei Q; Xia P; Ma W; Li L
Dis Markers; 2022; 2022():1909196. PubMed ID: 35075375
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment.
Chen B; Zhang S; Li Q; Wu S; He H; Huang J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146700
[TBL] [Abstract][Full Text] [Related]
5. The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment.
Hu H; Chen Y; Tan S; Wu S; Huang Y; Fu S; Luo F; He J
Front Immunol; 2022; 13():802846. PubMed ID: 35281003
[TBL] [Abstract][Full Text] [Related]
6. Dihydropyrimidine Dehydrogenase (DPD) as a Bridge between the Immune Microenvironment of Colon Cancers and 5-FU Resistance.
Cui Z; He S; Wen F; Lu L; Xu L; Wu H; Wu S
Front Biosci (Landmark Ed); 2023 Apr; 28(4):80. PubMed ID: 37114540
[TBL] [Abstract][Full Text] [Related]
7. Editorial: Complexity of tumor microenvironment: A major culprit in cancer development, volume II.
Bukhari I; Zhang Y; Thorne RF; Mi Y
Front Endocrinol (Lausanne); 2022; 13():1126778. PubMed ID: 36714569
[No Abstract] [Full Text] [Related]
8. Modulating MGMT expression through interfering with cell signaling pathways.
Bai P; Fan T; Wang X; Zhao L; Zhong R; Sun G
Biochem Pharmacol; 2023 Sep; 215():115726. PubMed ID: 37524206
[TBL] [Abstract][Full Text] [Related]
9. The next big questions in cancer research.
Loi S; Settleman J; Joyce JA; Pramesh CS; Bernards R; Fan J; Merchant JL; Moslehi J; Sellers WR
Cell; 2023 Apr; 186(8):1523-1527. PubMed ID: 37059060
[TBL] [Abstract][Full Text] [Related]
10. Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis.
Lee Y; Ni J; Beretov J; Wasinger VC; Graham P; Li Y
Mol Cancer; 2023 Feb; 22(1):33. PubMed ID: 36797736
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers.
Wang Y; Deng B
Cancer Metastasis Rev; 2023 Sep; 42(3):629-652. PubMed ID: 36729264
[TBL] [Abstract][Full Text] [Related]
12. Salivary biomarkers in cancer.
Eftekhari A; Maleki Dizaj S; Sharifi S; Salatin S; Khalilov R; Samiei M; Zununi Vahed S; Ahmadian E
Adv Clin Chem; 2022; 110():171-192. PubMed ID: 36210075
[TBL] [Abstract][Full Text] [Related]
13. Molecular Biomarkers in Cancer.
Sarhadi VK; Armengol G
Biomolecules; 2022 Jul; 12(8):. PubMed ID: 35892331
[TBL] [Abstract][Full Text] [Related]
14. Tumor Biomarker In-Solution Quantification, Standard Production, and Multiplex Detection.
Japp NC; Souchek JJ; Sasson AR; Hollingsworth MA; Batra SK; Junker WM
J Immunol Res; 2021; 2021():9942605. PubMed ID: 34514003
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
